Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: Eberconazol; Eberconazole nitrate; Ebernet; WAS 2160

Latest Information Update: 08 Nov 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chiesi Wassermann
  • Developer Chiesi Wassermann; SALVAT
  • Class Antifungals; Cycloheptanes; Imidazoles; Small molecules
  • Mechanism of Action Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes

Highest Development Phases

  • Marketed Mycoses; Tinea

Most Recent Events

  • 05 Sep 2007 Launched for Mycoses in India (Topical)
  • 05 Sep 2007 Launched for Tinea in India (Topical)
  • 31 Dec 2006 Eberconazole is available for licensing in European countries other than Spain (http://www.salvat-lab.es)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top